Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs SkyWest Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while SkyWest Inc trades at $96.42 (market cap $3.76B). The key difference: SkyWest Inc is far larger — about 2.2× Nuvation Bio Inc. Class A Common Stock's market cap, and SkyWest Inc is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and SkyWest Inc for 8 Days on average.
| NUVB | SKYW | |
|---|---|---|
Market Cap | $1.71B | $3.76B |
Volume | 5,448,712 | 296,298 |
Sector | Health | Industrials |
52-Week High | $9.54 | $115.94 |
52-Week Low | $3.41 | $78.40 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $1.30B | $5.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SkyWest (SKYW) trades at $96.64, down 1.1% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026, with revenue growth from $4.1B in 2025 to $4.2B in 2026. Analyst consensus is bullish with a $112 price target, supported by fleet upgrades and flying agreements, though net income margin dipped to 9.78% in 2026.
The outlook is cautiously optimistic given strong analyst buy ratings and undervalued metrics like a P/E of 9.6, but risks include cost pressures, insider selling, and technical bearishness. Upside hinges on execution of growth initiatives amid competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
